Surgery Partners (SGRY) PT Lowered to $17 at TD Cowen
Tweet
Share
E-mailGet Alerts SGRY Hot Sheet
Price: $13.89 --0%
Rating Summary:
12 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 30
Rating Summary:
12 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 30
Join SI Premium – FREE
TD Cowen analyst Ryan Langston lowered the price target on Surgery Partners (NASDAQ: SGRY) to $17.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- Piper Sandler Double Downgrades Myriad Genetics (MYGN) to Underweight, 'Major Strategic Action Likely Needed'
- Standard Nuclear (STDN) PT Raised to $20 at UBS
- JPMorgan Upgrades Inari Amertron Bhd (INRI:MK) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
